Refractory juvenile idiopathic arthritis

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Best Practice & Research Clinical Haematology

• Publication date

  2004-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.BEHA.2004.05.003
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: analysis of clinical effects, mortality, and transplant related morbidity

  2004cited by this paper
• Long-term follow-up of autologous stem cell transplantation for refractory juvenile idiopathic arthritis

  2003cited by this paper
• Phase II trial of anti-IL-6 receptor antibody (MRA) for children with systemic-onset juvenile idiopathic arthritis

  2003cited by this paper
• Long term follow up of immune repertoire after severe immunosuppression and autologous stem cell rescue in children with juvenile idiopathic arthritis.

  2003cited by this paper
• Autologous haematopoietic stem cell transplantation in juvenile idiopathic arthritis

  2003cited by this paper
• Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome.

  2003cited by this paper
• The benefits of early treatment in rheumatoid arthritis: confounding by indication, and the issue of timing.

  2003cited by this paper
• The spontaneous remission of juvenile idiopathic arthritis is characterized by CD30+ T cells directed to human heat-shock protein 60 capable of producing the regulatory cytokine interleukin-10.

  2003cited by this paper
• Macrophage activation syndrome following initiation of etanercept in a child with systemic onset juvenile rheumatoid arthritis.

  2003cited by this paper
• Systemic juvenile idiopathic arthritis, Kikuchi's disease and haemophagocytic lymphohistiocytosis--is there a link? Case report and literature review.

  2003cited by this paper
• Reduced perforin expression in systemic juvenile idiopathic arthritis is restored by autologous stem-cell transplantation.

  2003cited by this paper
• Most antiviral CD8 T cells during chronic viral infection do not express high levels of perforin and are not directly cytotoxic.

  2003cited by this paper
• Macrophage activation syndrome and reactive hemophagocytic lymphohistiocytosis: the same entities?

  2003cited by this paper
• Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type.

  2003cited by this paper
• Macrophage activation syndrome after autologous stem cell transplantation for systemic juvenile idiopathic arthritis

  2002cited by this paper
• The fraction of perforin-expressing HIV-specific CD8 T cells is a marker for disease progression in HIV infection

  2002cited by this paper
• Haemophagocytic lymphohistiocytosis: proposal of a diagnostic algorithm based on perforin expression

  2002cited by this paper
• Macrophage activation syndrome is hemophagocytic lymphohistiocytosis--need for the right terminology.

  2002cited by this paper
• Treatment of refractory juvenile idiopathic arthritis.

  2001cited by this paper
• Pathogenesis of haemophagocytic lymphohistiocytosis

  2001cited by this paper
• Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients.

  2001cited by this paper
• Intense immunosuppression followed by purified blood CD34+ cell autografting in a patient with refractory juvenile rheumatoid arthritis

  2001cited by this paper
• Autologous stem cell transplantation for pediatric rheumatic diseases.

  2001cited by this paper
• Early predictors of poor functional outcome in systemic-onset juvenile rheumatoid arthritis: a multicenter cohort study.

  2000cited by this paper
• Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group.

  2000cited by this paper
• Perforin gene defects in familial hemophagocytic lymphohistiocytosis.

  1999cited by this paper
• Pediatric Escola Paulista de Medicina Range of Motion Scale: a reduced joint count scale for general use in juvenile rheumatoid arthritis.

  1999cited by this paper
• Prognosis in children with rheumatic diseases: justification for consideration of new therapies.

  1999cited by this paper
• Effectiveness and risks of total body irradiation for conditioning in the treatment of autoimmune disease with autologous bone marrow transplantation

  1999cited by this paper
• Haemopoietic stem-cell transplantation for juvenile chronic arthritis.

  1999cited by this paper
• Performance of the preliminary definition of improvement in juvenile chronic arthritis patients treated with methotrexate

  1998cited by this paper
• Immune reconstitution and immunotherapy after autologous hematopoietic stem cell transplantation.

  1998cited by this paper
• Trial of intravenous pulse cyclophosphamide and methylprednisolone in the treatment of severe systemic-onset juvenile rheumatoid arthritis.

  1997cited by this paper
• Bone marrow transplantation in the treatment of autoimmune diseases.

  1997cited by this paper
• Preliminary definition of improvement in juvenile arthritis.

  1997cited by this paper
• Macrophage activation syndrome in systemic juvenile rheumatoid arthritis successfully treated with cyclosporine.

  1996cited by this paper
• Efficacy of cyclosporine A in the treatment of macrophage activation syndrome in juvenile arthritis: report of five cases.

  1996cited by this paper
• Reduced joint counts in controlled clinical trials in rheumatoid arthritis.

  1994cited by this paper
• Measurement of health status in children with juvenile rheumatoid arthritis.

  1994cited by this paper
• Macrophage activation syndrome and rheumatic disease in childhood: a report of four new cases.

  1993cited by this paper
• Toxicity of sulfasalazine in systemic juvenile chronic arthritis.

  1991cited by this paper
• Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis

  1987cited by this paper

• Lymphohistiocytose hémophagocytaire

  2022cites this paper
• Hematopoietic stem cell transplantation in autoimmune disorders: From immune-regulatory processes to clinical implications.

  2017cites this paper
• Fever of Unknown Origin with Polyarthritis

  2016cites this paper
• Lymphohystiocytose hémophagocytaire

  2014cites this paper
• Advances in the pathogenesis and treatment of systemic juvenile idiopathic arthritis

  2014cites this paper
• Autologous haemopoietic stem cell transplantation for autoimmune diseases

  2011cites this paper
• Autologous stem cell transplantation in autoimmune and rheumatic diseases: from the molecular background to clinical applications

  2010cites this paper
• Autologous hematopoietic stem cell transplantation in autoimmune diseases

  2009cites this paper
• Hematopoietic stem cell transplantation for pediatric autoimmune disease: where we stand and where we need to go

  2009cites this paper
• Intensification thérapeutique dans les maladies auto-immunes

  2008cites this paper
• Regenerating musculoskeletal tissues: possibilities for rheumatoid diseases

  2008cites this paper
• Cell therapy for autoimmune diseases

  2007cites this paper
• Immune Regeneration Through Hematopoietic Stem Cell Transplantation to Restore Tolerance in Autoimmune Disease

  2007cites this paper
• Review Cell therapy for autoimmune diseases

  2007cites this paper
• 13 – Stem Cell Transplantation for Autoimmune Diseases

  2007cites this paper
• Macrophage activation syndrome and other systemic inflammatory conditions after BMT

  2006cites this paper
• Hematopoietic and mesenchymal stem cell transplantation in autoimmune diseases

  2006cites this paper
• Adult stem cells in the treatment of autoimmune diseases.

  2006cites this paper
• Haemophagocytic syndromes in adults: current concepts and challenges ahead.

  2005cites this paper
• Progress in hematopoietic stem cell transplantation for autoimmune diseases

  2005cites this paper
• Autologous Hematopoietic Stem Cell Transplantation for Autoimmune Diseases

  2005cites this paper
• Haematopoietic stem cell transplantation in the treatment of severe autoimmune disease: results from phase I/II studies, prospective randomized trials and future directions

  2005cites this paper